Long-CoV-III-21 trial shows positive results for bovhyaluronidase azoximer in post-COVID pulmonary…
Petrovax announced today the positive results from "Long-CoV-III-21," a randomized, double-blind, placebo-controlled trial evaluating the efficacy and safety of bovhyaluronidase azoximer in adult patients with pulmonary…
Read More...
Read More...